Citigroup »

Kiniksa Pharmaceuticals shares owned by Citigroup

Quarter-by-quarter ownership of Kiniksa Pharmaceuticals (KNSA) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Kiniksa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kiniksa Pharmaceuticals held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kiniksa Pharmaceuticals by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $834k 46k 18.00
2023-09-30 $2.2M 124k 17.37
2023-03-31 $3.6M 333k 10.76
2022-12-31 $3.8M 253k 14.98
2022-09-30 $938k 72k 13.04
2021-12-31 $869k 74k 11.77
2021-03-31 $2.5M 137k 18.51
2020-12-31 $115k 6.5k 17.68
2020-09-30 $24k 1.6k 15.37
2020-06-30 $145k 5.7k 25.48
2020-03-31 $61k 3.9k 15.46
2019-12-31 $31k 2.8k 11.08
2019-09-30 $13k 1.2k 10.75
2019-06-30 $58k 4.3k 13.41
2019-03-31 $62k 3.4k 18.20
2018-12-31 $40k 1.4k 28.74
2018-09-30 $48k 1.9k 25.46